A polymorphism in the thyroid hormone receptor gene is associated with bronchodilator response in asthmatics by Duan Q L, Du R, Lasky-Su J, Klanderman B J, Partch A B, Peters S P, Irvin C G, Hanrahan J P, Lima J J, Blake K V, Liggett S B, Litonjua A A, Tantisira K G in The pharmacogenomics journal (2012).

[PMID: 22212731] PubMed


A pro-asthmatic culture milieu and beta(2)-agonist (isoproterenol) were previously shown to regulate the expression of select transcription factors (TFs) within human airway epithelial and smooth muscle cells. This study tests 1116 single-nucleotide polymorphisms (SNPs) across 98 of these TF genes for association with bronchodilator response (BDR) in asthma patients. Genotyping was conducted using the Illumina HumanHap550v3 Beadchip in 403 non-Hispanic White asthmatic children and their parents. SNPs were evaluated for association with BDR using family and population-based analyses. Forty-two SNPs providing P-values <0.1 in both analyses were then genotyped in three adult asthma trials. One SNP 5' of the thyroid hormone receptor-beta gene was associated with BDR in the childhood population and two adult populations (P-value=0.0012). This investigation identified a novel locus for inter-individual variability in BDR and represents a translation of a cellular drug-response study to potential personalization of clinical asthma management.The Pharmacogenomics Journal advance online publication, 3 January 2012; doi:10.1038/tpj.2011.56.

[ hide abstract ]

Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Rx Annotations

No dosing information annotated.